Innovent Biologics1801 
$4.612.14%24h
2.14%24h
Global rank1955
Market cap$7.42B
Change 7d-7.49%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Innovent Biologics (1801)
As of January 2025, Innovent Biologics has a market cap of $7.42B. This makes Innovent Biologics the world's 1955th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innovent Biologics from 2018 to 2024
-
Value:-
Market cap history of Innovent Biologics from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $7.73B | -12.75% |
| 2023 | $8.86B | 27.61% |
| 2022 | $6.95B | -30.57% |
| 2021 | $10.00B | -41.73% |
| 2020 | $17.17B | 211.86% |
| 2019 | $5.50B | 10.17% |
| 2018 | $5.00B | - |
1801 Market Cap Today is $7.42B 2.14% - 16 Jan 2025
View largest stocks by market cap 
